trial · primary record
Deucravacitinib
Plaque Psoriasis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 366 |
| Primary completion | 2034-08-12 |
| Primary endpoint | Number of participants achieving at least 75% improvement in Psoriasis Area and Severity Index (PASI 75) |
| Registry ID | NCT06979453 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:09.079Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06979453
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.